[HTML][HTML] Cost-Effectiveness Analysis of Prostate Cancer Screening in Brazil
RAR de Oliveira, TC Mourão, TBM Santana… - Value in Health …, 2021 - Elsevier
Introduction: Prostate cancer is one of the most common malignancies among men
worldwide. Prostate-specific antigen (PSA) screening shows uncertain benefits and harms …
worldwide. Prostate-specific antigen (PSA) screening shows uncertain benefits and harms …
Development and external validation of multiparametric MRI-derived nomogram to predict risk of pathologic upgrade in patients on active surveillance for prostate …
SH Kim - American Journal of Roentgenology, 2020 - Am Roentgen Ray Soc
OBJECTIVE. The aim of this study was to create, develop, and externally validate a
nomogram that predicts pathologic upgrade in patients on active surveillance (AS) for …
nomogram that predicts pathologic upgrade in patients on active surveillance (AS) for …
Uso da ressonância magnética multiparamétrica na vigilância ativa do câncer de próstata: Uma revisão integrativa
JMF de Oliveira Neto, ES Ferreira Filho… - Research, Society and …, 2024 - rsdjournal.org
Introduction: Prostate cancer is the second most common malignancy in males, with an
increasing incidence due to improvements in diagnostic methods, such as multiparametric …
increasing incidence due to improvements in diagnostic methods, such as multiparametric …
Prostat kanseri tanısı ile radikal prostatektomi yapılan hastalarda östrojen reseptörü α ve β'nın biyokimyasal rekürrense etkisinin analizi
YM Aydın - 2022 - acikerisim.uludag.edu.tr
Giriş: Prostat kanseri 50 yaşından itibaren erkeklerde en sık görülen ve başlıca androjen
bağımlı bir kanser türüdür. Ancak prostat kanseri gelişiminde östrojenin de etkili olduğu …
bağımlı bir kanser türüdür. Ancak prostat kanseri gelişiminde östrojenin de etkili olduğu …
Prostat Kanseri̇ Tanisi İle Radi̇kal Prostatektomi̇ Yapilan Hastalarda Östrojen Reseptörü α ve β'Nin Bi̇yoki̇myasal Rekürrense Etki̇si̇ni̇n Anali̇zi̇
YM Aydın - 2022 - search.proquest.com
Giriş: Prostat kanseri 50 yaşından itibaren erkeklerde en sık görülen ve başlıca androjen
bağımlı bir kanser türüdür. Ancak prostat kanseri gelişiminde östrojenin de etkili olduğu …
bağımlı bir kanser türüdür. Ancak prostat kanseri gelişiminde östrojenin de etkili olduğu …
REPEATED MRI SCANS DURING ACTIVE SURVEILLANCE FOR PROSTATE CANCER: NATURAL HISTORY OF PROSTATIC LESIONS AND UPGRADING RATES …
S Luzzago - 2021 - air.unimi.it
Objectives To test upgrading rates in patients on Active Surveillance (AS) for prostate cancer
(PCa) after serial multiparametric magnetic resonance imaging (mpMRI) scans. Materials …
(PCa) after serial multiparametric magnetic resonance imaging (mpMRI) scans. Materials …
Clinical utility of MR/ultrasound fusion-guided biopsy in patients with lower suspicion lesions on active surveillance for low-risk prostate cancer
SD Lokeshwar, J Nguyen, SN Rahman, G Khajir… - … Oncology: Seminars and …, 2022 - Elsevier
Abstract Background The utility of Multiparametric magnetic resonance imaging (mpMRI)
guided prostate biopsy among patients with prostate cancer (CaP) managed with active …
guided prostate biopsy among patients with prostate cancer (CaP) managed with active …
[HTML][HTML] The role of multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy in active surveillance for low-risk prostate cancer: A …
SZ Alshehri, OS Alshahrani, NA Almsaoud… - Annals of Medicine and …, 2020 - Elsevier
The performance of multiparametric magnetic resonance imaging (mpMRI) and subsequent
biopsy in monitoring prostate cancer in men on active surveillance (AS) have not been …
biopsy in monitoring prostate cancer in men on active surveillance (AS) have not been …
Doubling of Decipher Biopsy Genomic Score Is Related to Disease Reclassification on Subsequent Surveillance Biopsy but Not Adverse Features on Radical …
K Ghabili, N Paulson, JS Syed, CB Nawaf… - Case Reports in …, 2021 - Wiley Online Library
The utility of serial Decipher biopsy scores in a true active surveillance population is still
unknown. In a man on active surveillance for low‐risk prostate cancer, a doubling of the …
unknown. In a man on active surveillance for low‐risk prostate cancer, a doubling of the …